tiprankstipranks
CSL Limited (CSLLY)
OTHER OTC:CSLLY

CSL (CSLLY) Stock Price & Analysis

42 Followers

CSLLY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$73.07 - $103.42
Previous Close$93.41
Volume13.18K
Average Volume (3M)36.94K
Market Cap
$90.64B
Enterprise Value$89.56B
Total Cash (Recent Filing)$10.44B
Total Debt (Recent Filing)$9.66B
Price to Earnings (P/E)35.6
Beta0.60
Aug 13, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)2.59
Shares Outstanding964,738,522
10 Day Avg. Volume28,991
30 Day Avg. Volume36,939
Standard Deviation0.07
R-Squared0.35
Alpha-0.00035
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit15.81
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%0.01%99.98%
0.00%
Insiders
0.01% Other Institutional Investors
99.98% Public Companies and
Individual Investors

CSLLY FAQ

What was CSL Limited’s price range in the past 12 months?
CSL Limited lowest stock price was $73.07 and its highest was $103.42 in the past 12 months.
    What is CSL Limited’s market cap?
    Currently, no data Available
    When is CSL Limited’s upcoming earnings report date?
    CSL Limited’s upcoming earnings report date is Aug 13, 2024 which is in 137 days.
      How were CSL Limited’s earnings last quarter?
      CSL Limited released its earnings results on Feb 12, 2024. The company reported $1.969 earnings per share for the quarter, beating the consensus estimate of N/A by $1.969.
        Is CSL Limited overvalued?
        According to Wall Street analysts CSL Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CSL Limited pay dividends?
          CSL Limited pays a Semiannually dividend of $0.55 which represents an annual dividend yield of 1.17%. See more information on CSL Limited dividends here
            What is CSL Limited’s EPS estimate?
            CSL Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does CSL Limited have?
            CSL Limited has 966,505,430 shares outstanding.
              What happened to CSL Limited’s price movement after its last earnings report?
              CSL Limited reported an EPS of $1.969 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.789%.
                Which hedge fund is a major shareholder of CSL Limited?
                Among the largest hedge funds holding CSL Limited’s share is Fisher Asset Management LLC. It holds CSL Limited’s shares valued at 3M.
                  ---

                  Company Description

                  CSL Limited

                  CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Becton Dickinson
                  Thermo Fisher
                  Roche Holding
                  Abbott Labs
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis